2m 2m 2m 2m 2m 2m 2m
Alpha Tau Med (DRTS)
NASDAQ
$15.02+$0.10 (+0.64%)
Price as of Aug 21, 2026 7:48 PM EDT- $497.5MMarket Cap
- 372.15%1-Year Change
- BiotechnologyIndustry
Alpha Tau Med (DRTS)
$15.02+$0.10 (+0.64%)
DRTS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $14.92 | ||
Change | +$0.56 (+3.90%) | ||
Open | $14.57 | ||
High | $15.02 | ||
Low | $14.40 | ||
Previous Close | $14.36 | ||
Volume | 626,207 | ||
30-Day Average Volume | 522,962 | ||
1-Week Change | 4.70% | ||
1-Month Change | 12.01% | ||
1-Year Change | 372.15% | ||
3-Year Change | 321.47% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 33.3M | ||
Total Assets | $105.7M | ||
Market Cap | $497.5M | ||
Enterprise Value | $491.6M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | N/A | ||
EBIT | N/A | ||
EBITDA | N/A | ||
Net Working Capital | N/A | ||
EPS | N/A | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue